Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Hormone and Metabolic Research. Supplement Series|January 1, 1990
Swine islet isolation and transplantationC Ricordi, C Socci, A M Davalli, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1990
Selection of donors significantly improves pig islet isolation yieldC Socci, C Ricordi, A M Davalli, et al.
Diabetologia|September 1, 1990
Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patientsL Luzi, A Secchi, F Facchini, et al.
Hepatology (Baltimore, Md.)|May 1, 1995
Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic ClubM Primignani, B Andreoni, L Carpinelli, et al.
Tumori|January 1, 1995
The role of intraoperative therapy by electron beam and combination of adjuvant chemotherapy and external radiotherapy in carcinoma of the pancreasV Fossati, G M Cattaneo, A Zerbi, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|November 1, 1989
CT-guided pancreatic percutaneous fine-needle biopsy in differential diagnosis between pancreatic cancer and chronic pancreatitisM Carlucci, A Zerbi, D Parolini, et al.
American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.
Diabetologia|August 1, 1991
Pancreas and kidney transplantation: the San Raffaele Hospital (Milan, Italy) experienceV Di Carlo, C Staudacher, M Cristallo, et al.
Diabetologia|August 1, 1991
Effect of pancreas transplantation on life expectancy, kidney function and quality of life in uraemic type 1 (insulin-dependent) diabetic patientsA Secchi, V Di Carlo, S Martinenghi, et al.
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.
Pageof 12